Winning Points Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $654K | Sell |
10,778
-30
| -0.3% | -$1.75K | 0.87% | 23 |
|
|
2025
Q4 | $583K | Buy |
+10,808
| New | +$520K | 0.62% | 24 |
|
|
2024
Q3 | $726K | Buy |
+12,481
| New | +$585K | 1.22% | 16 |
|
|
2024
Q1 | $615K | Hold |
11,981
| – | – | 0.95% | 17 |
|
|
2023
Q4 | $615K | Sell |
11,981
-500
| -4% | -$26.2K | 0.95% | 17 |
|
|
2023
Q3 | $726K | Buy |
12,481
+500
| +4% | +$30.6K | 1.29% | 14 |
|
|
2023
Q2 | $615K | Sell |
11,981
-500
| -4% | -$33.5K | 0.95% | 17 |
|
|
2023
Q1 | $865K | Buy |
12,481
+85
| +0.7% | +$6K | 0.95% | 22 |
|
|
2022
Q4 | $892K | Sell |
12,396
-115
| -0.9% | -$8.67K | 1.14% | 22 |
|
|
2022
Q3 | $902K | Buy |
12,511
+100
| +0.8% | +$7.25K | 1.1% | 22 |
|
|
2022
Q2 | $955K | Hold |
12,411
| – | – | 1.05% | 22 |
|
|
2022
Q1 | $906K | Sell |
12,411
-255
| -2% | -$17.1K | 0.7% | 30 |
|
|
2021
Q4 | $574K | Buy |
12,666
+255
| +2% | +$15K | 0.42% | 44 |
|
|
2021
Q3 | $734K | Hold |
12,411
| – | – | 0.54% | 36 |
|
|
2021
Q2 | $829K | Sell |
12,411
-100
| -0.8% | -$6.52K | 0.62% | 33 |
|
|
2021
Q1 | $790K | Buy |
12,511
+45
| +0.4% | +$2.8K | 0.59% | 37 |
|
|
2020
Q4 | $773K | Sell |
12,466
-100
| -0.8% | -$6.15K | 0.62% | 32 |
|
|
2020
Q3 | $758K | Hold |
12,566
| – | – | 0.65% | 32 |
|
|
2020
Q2 | $739K | Hold |
12,566
| – | – | 0.71% | 30 |
|
|
2020
Q1 | $700K | Hold |
12,566
| – | – | 0.68% | 31 |
|
|
2019
Q4 | $807K | Buy |
12,566
+200
| +2% | +$11.5K | 0.51% | 38 |
|
|
2019
Q3 | $621K | Sell |
12,366
-300
| -2% | -$14.1K | 0.45% | 43 |
|
|
2019
Q2 | $574K | Hold |
12,666
| – | – | 0.42% | 44 |
|
|
2019
Q1 | $604K | Hold |
12,666
| – | – | 0.47% | 43 |
|
|
2018
Q4 | $664K | Sell |
12,666
-66
| -0.5% | -$3.55K | 0.57% | 37 |
|
|
2018
Q3 | $790K | Hold |
12,732
| – | – | 0.58% | 37 |
|
|
2018
Q2 | $705K | Hold |
12,732
| – | – | 0.56% | 38 |
|
|
2018
Q1 | $795K | Hold |
12,732
| – | – | 0.65% | 36 |
|
|
2017
Q4 | $780K | Hold |
12,732
| – | – | 0.64% | 35 |
|
|
2017
Q3 | $812K | Sell |
12,732
-140
| -1% | -$8.18K | 0.7% | 34 |
|
|
2017
Q2 | $724K | Buy |
12,872
+128
| +1% | +$6.96K | 0.71% | 35 |
|
|
2017
Q1 | $693K | Hold |
12,744
| – | – | 0.68% | 37 |
|
|
2016
Q4 | $745K | Buy |
+12,744
| New | +$697K | 0.81% | 35 |
|
Other funds holding BMY
VCM
VPM
Winning Points Advisors's BMY Position: Q1 2026 in Review
Winning Points Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.28% in Q1 2026, selling an estimated $1.75K and leaving 10,778 shares worth $654K. The position accounts for 0.87% of the portfolio, ranked #23.
Winning Points Advisors first reported a position in BMY in Q4 2016 and has held it in 33 quarters since. The position peaked at $955K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Winning Points Advisors held 10,778 shares of Bristol-Myers Squibb worth $654K as of Q1 2026.
- Winning Points Advisors sold 30 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.75K.
- Bristol-Myers Squibb made up 0.87% of Winning Points Advisors's portfolio in Q1 2026, its #23 holding.
- Winning Points Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 33 quarters since.
- Winning Points Advisors's Bristol-Myers Squibb position peaked at $955K in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Winning Points Advisors's 13F filing for Q1 2026, filed 30 Jun 2026.